The aesthetics division earned $5.2bn in 2024, down 2% year-on-year, while neuroscience revenues came to $8.99bn, up 17% year-on-year, driven by Botox - $3.3bn of revenues as a migraine therapy ...

Sales from the neuroscience portfolio increased 19.9% to $2.51 billion, driven by higher sales of Botox Therapeutic, depression drug Vraylar, and migraine ... gained about 5% against the industry ...

This robust performance is driven by continued double-digit growth of Vraylar with global sales of $924 million, Botox Therapeutic ... for psychiatry and migraine, we are very excited for an ...

If the FDA does approve the drug, ubrogepant will however have to compete head-to-head against Eli Lilly ... with wrinkle treatment Botox - also used for migraine prevention - to drive take ...

Daw, 25, heads to Dallas this week for intricate surgery to address idiopathic condylar resorption, a degenerative and ...

Suicide is a complex issue caused by many factors, and experts warn against trying to "solve ... feels like he needs it. He gets Botox injections for his migraines and does brain training ...

We’re living in an era of “tweakments,” where minimally invasive cosmetic procedures like Botox and filler have been reduced to nothing more than an ordinary step in one’s skincare regimen.

More common side effects in adults using Botox for migraine include: injection site reaction muscle weakness close to where Botox is injected flu-like symptoms such as fever, nausea, and achy ...

Botox injections have been FDA approved to treat excessive sweating. In the skin, Botox selectively turns off the sweat glands resulting in a normal appearance without wetness. Treatment is performed ...